Beyond Point Solutions: Cardiometabolic Total Cost of Care

For health plans, cardiometabolic care is becoming increasingly complex.  As diabetes, hypertension, obesity and GLP-1 use increasingly overlap within the same member population, they are navigating a growing ecosystem of condition-specific vendors, internal solutions and competing operating models. The result is a fragmented ecosystem where demonstrating clinical impact, proving impact on the overall patient journey and total cost of care can be challenging.

Patients don't experience cardiometabolic conditions in silos so why does the system still manage them that way?

This private roundtable, co-hosted by HLTH and Omada brings together senior clinical, product and partnership leaders from US payers and health plans for a candid peer-to-peer discussion on the challenges of vendor sprawl, build-versus-partner decisions, how to assess clinical outcomes across multiple interventions and how to determine which approaches can genuinely improve care while contributing to better total cost of care.

By applying to this event, you agree to our Terms and Privacy Notice.